• Home
  • Business Core
  • R&D Pipeline
  • About Us
  • Tech Platform
    • Tech Platform
    • Tech Advantages
  • News Center
    • Company News
    • Academic Achievements
  • Contact
  • 中

News Center

Company News

  • Company News
  • Academic Achievements
    2024.12.13
    The expert team of NeoAgro visited MoMed Biotech and jointly discussed the new blueprint for cooperation.

    On December 12th, 2024, a delegation including Zhang Jianrong, the director of Zhejiang NeoAgro Chemical Co., Ltd., scientist Song Zhongshu, Dr. Zeng Jiamei from the R & D department, and teacher Xu Danqian from Zhejiang University of Technology visited MoMed Biotech for communication and guidance. They had in-depth technical exchanges with Bai Chen, the chairman of MoMed Biotech, and explored the possibilities of future cooperation.

    2024.11.22
    MOMED Biotech has joined hands with Zhejiang XIANJU PHARMA to jointly initiate a new drug molecular design project.

    2024.10.31
    The chief scientist of MoMed Biotech has been elected as a member of the American Academy of Sciences and Letters.

    2024.09.30
    Nobel Laureate Encounter | The chief scientist of MoMed Biotech ushers in a new chapter of technological exchange and innovation.

    In September 2024, we had a precious encounter with Professor Arieh Warshel, the chief scientist of MoMed Biotech, a member of the National Academy of Sciences of the United States and the winner of the 2013 Nobel Prize in Chemistry. Professor Warshel personally visited MoMed Biotech and had in-depth exchanges with the research and development team to understand the latest progress of research and development projects and gave highly professional guidance.

    2024.04.16
    MoMed Biotech Tiantai Visit: Deepening Cooperation and Seeking Development Together

<<<
    12345
>>>
  • Address: 4th Floor, Building 1, 600 Hongfeng Road, Linping District, Hangzhou City, Zhejiang Province

    Email: momedbusiness@momed.com.cn

    Phone: (0571) - 8610 3711


    • Corporate Official Account

    • Research Group Website

    • Business Core Business Core R&D Pipeline
    • About Us Company Profile Founding Team Development History
    • Tech Platform Research Platform for Mechanism of Target Proteins Artificial Intelligence Platform for Mining New Disease Pathways Target Protein Kinetics Database Artificial Intelligence Small Molecule Drug Design Platform AI-Based Macromolecular Drug Design Platform Multi-pipeline drug R&D platform Artificial Intelligence Platform for Predicting ADMET Properties of Drugs
    • News Center Company News Academic Achievements
    • Contact MoMed Contact Information Join MoMed
  • 2023 晨伫科技 浙ICP备2023014953号-1
  • 网站声明 | 隐私政策